398 related articles for article (PubMed ID: 8574725)
1. Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C.
Berenguer M; Olaso V; Córdoba J; Gobernado M; Carrasco D; Berenguer J
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):899-903. PubMed ID: 8574725
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.
Kessler HH; Pierer K; Santner BI; Vellimedu SK; Stelzl E; Marth E; Fickert P; Stauber RE
J Hum Virol; 1998; 1(5):314-9. PubMed ID: 10195258
[TBL] [Abstract][Full Text] [Related]
3. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J
Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209
[TBL] [Abstract][Full Text] [Related]
4. Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after alpha-interferon therapy.
García-Bengoechea M; Basaras M; Barrio J; Arrese E; Montalvo II; Arenas JI; Cisterna R
Am J Gastroenterol; 1999 Jul; 94(7):1902-5. PubMed ID: 10406257
[TBL] [Abstract][Full Text] [Related]
5. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
[TBL] [Abstract][Full Text] [Related]
6. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
Xu DZ; Xie Y; Li ZQ
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
[TBL] [Abstract][Full Text] [Related]
7. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.
Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G
Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712
[TBL] [Abstract][Full Text] [Related]
8. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
9. Choice of appropriate end points of response to interferon therapy in chronic hepatitis C virus infection.
Davis GL; Lau JY
J Hepatol; 1995; 22(1 Suppl):110-4. PubMed ID: 7602061
[TBL] [Abstract][Full Text] [Related]
10. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
[TBL] [Abstract][Full Text] [Related]
11. Patterns of hepatitis C viremia in patients receiving hemodialysis.
Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
[TBL] [Abstract][Full Text] [Related]
12. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
[TBL] [Abstract][Full Text] [Related]
13. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver].
Hige S
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection.
Chang TT; Young KC; Yang YJ; Lei HY; Wu HL
Hepatology; 1996 May; 23(5):977-81. PubMed ID: 8621178
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy.
Larghi A; Tagger A; Crosignani A; Ribero ML; Bruno S; Portera G; Battezzati PM; Maggioni M; Fasola M; Zuin M; Podda M
J Med Virol; 1998 May; 55(1):7-11. PubMed ID: 9580879
[TBL] [Abstract][Full Text] [Related]
16. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells.
Zaghloul H; El-Sherbiny W
Immunol Invest; 2010 Jan; 39(3):284-91. PubMed ID: 20380524
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.
Pramoolsinsap C; Poovorawan Y; Sura T; Theamboonlers A; Busagorn N; Kurathong S
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):480-90. PubMed ID: 10437943
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
[TBL] [Abstract][Full Text] [Related]
20. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]